Correlation Between Israel China and Epitomee Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Israel China and Epitomee Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Israel China and Epitomee Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Israel China Biotechnology and Epitomee Medical, you can compare the effects of market volatilities on Israel China and Epitomee Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Israel China with a short position of Epitomee Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Israel China and Epitomee Medical.

Diversification Opportunities for Israel China and Epitomee Medical

-0.75
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Israel and Epitomee is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Israel China Biotechnology and Epitomee Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Epitomee Medical and Israel China is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Israel China Biotechnology are associated (or correlated) with Epitomee Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Epitomee Medical has no effect on the direction of Israel China i.e., Israel China and Epitomee Medical go up and down completely randomly.

Pair Corralation between Israel China and Epitomee Medical

Assuming the 90 days trading horizon Israel China Biotechnology is expected to generate 0.85 times more return on investment than Epitomee Medical. However, Israel China Biotechnology is 1.17 times less risky than Epitomee Medical. It trades about 0.35 of its potential returns per unit of risk. Epitomee Medical is currently generating about -0.24 per unit of risk. If you would invest  50,000  in Israel China Biotechnology on August 25, 2024 and sell it today you would earn a total of  12,000  from holding Israel China Biotechnology or generate 24.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Israel China Biotechnology  vs.  Epitomee Medical

 Performance 
       Timeline  
Israel China Biotech 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Israel China Biotechnology are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak fundamental drivers, Israel China may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Epitomee Medical 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Epitomee Medical are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Epitomee Medical sustained solid returns over the last few months and may actually be approaching a breakup point.

Israel China and Epitomee Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Israel China and Epitomee Medical

The main advantage of trading using opposite Israel China and Epitomee Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Israel China position performs unexpectedly, Epitomee Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Epitomee Medical will offset losses from the drop in Epitomee Medical's long position.
The idea behind Israel China Biotechnology and Epitomee Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Stocks Directory
Find actively traded stocks across global markets